No Data
Regulus Therapeutics GAAP EPS of -$0.21 Misses by $0.04
Regulus Therapeutics | 10-Q: Quarterly report
Express News | Regulus Therapeutics Q3 Income From Operations USD -15.21 Million
Press Release: Regulus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Updates
Regulus Therapeutics 3Q Loss/Shr 21c >RGLS
Watching Regulus Therapeutics; Shares See Volume To The Upside As Traders Circulate TipRanks Article Titled 'These 2 'Strong Buy' Penny Stocks Could Rally Over 500%, Say Analysts'
No Data
No Data